AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concerns

Phase three trials for AstraZeneca’s coronavirus vaccine have resumed in the U.K. after they were halted earlier this week over safety concerns, the company announced Saturday.

AstraZeneca said it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials. The company declined to disclose medical information about the pause of the trial. 

This is breaking news. Check back here for updates.